Company Filing History:
Years Active: 2023
Title: Kyong Hoon Ahn: Innovator in Long-Acting Insulin Analogues
Introduction
Kyong Hoon Ahn is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of diabetes treatment through his innovative work on long-acting insulin analogues. With a total of 2 patents, Ahn's inventions aim to improve the quality of life for diabetic patients.
Latest Patents
Ahn's latest patents include a method for producing an active form of a long-acting insulin analogue derivative using clostripain. This invention addresses the challenges faced in conventional methods by allowing the insulin analogue to be converted to an active form without cleavage of the B-chain. This advancement is crucial for the effective production of long-acting therapeutic agents for diabetes treatment. Another notable patent focuses on long-acting insulin analogues that have an increased in vivo half-life. These analogues involve substitutions in the amino acids of the insulin chains, providing convenience for diabetic patients who self-administer insulin.
Career Highlights
Kyong Hoon Ahn is associated with Daewoong Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has garnered attention for its potential to enhance diabetes management through improved insulin formulations.
Collaborations
Ahn collaborates with notable colleagues, including Oh-Byung Kwon and Seung Woo Kim, contributing to a dynamic research environment that fosters innovation.
Conclusion
Kyong Hoon Ahn's contributions to the development of long-acting insulin analogues represent a significant advancement in diabetes treatment. His innovative methods and collaborative efforts continue to pave the way for improved therapeutic options for patients.